Frexalimab Has Favorable Effect on Relapsing Multiple Sclerosis
Generally favorable effect seen in terms of number of new gadolinium-enhancing T1-weighted lesions at week 12.
Source: empr.com
Page 2 - Patrick Vermersch News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Patrick Vermersch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Patrick Vermersch Today - Breaking & Trending Today
Novel Anti-CD40L Antibody Slows New Brain Lesions in Relapsing MS
Frexalimab shows promise in phase II study
Source: medpagetoday.com
New Data on CD40 Ligand Inhibitor for Relapsing MS
Novel agent led to sustained reduction of new lesions at 24 weeks
Source: medpagetoday.com
Novel Drug Shows Promise in Multiple Sclerosis
CD40 ligand inhibitor leads to sustained reduction of MRI disease activity
Source: medpagetoday.com
Ad Scientiam Launches International Study to Assess Disability Progression ...
Ad Scientiam Launches International Study to Assess Disability Progression ...
Source: pr-inside.com